The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

The journalist Kara Swisher discusses Elon Musk's goals in government — and the factors that have led to his radicalization.

So said an unnamed public speaker at Tuesday’s Shasta County Board of Supervisors meeting in apparent praise for Mangione, ...

PUT IT ON ICE — U.S. District Judge John Coughenour, a Reagan appointee, extended a temporary hold on Trump’s executive order ...